• Register
  • Login
  • Subscribe
  • Contact Us

Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (Dp1 Clinical Trial Optional)

USARFP notice for Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (Dp1 Clinical Trial Optional). The reference ID of the tender is 73488891 and it is closing on 25 Sep 2025.

Tender Details

  • Country: USA
  • Summary: Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (Dp1 Clinical Trial Optional)
  • UST Ref No: 73488891
  • Deadline: 25 Sep 2025
  • Financier: Self Financed
  • Purchaser Ownership: Government
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: PAR-23-021
  • Purchaser's Detail:
    Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
  • Description:
  • Tender are invited for Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)
    CFDA Number : 93.279 -- Drug Abuse and Addiction Research Programs
    Cost Sharing or Matching Requirement : No
    Closing Date for Applications: Sep 25, 2025
    Posted Date : Oct 21, 2022
    Description: Avenir means future in French, and this award looks toward the future by supporting early stage investigators proposing highly innovative studies. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field. NIDA has developed two Avenir Award Programs, one for HIV/AIDS research and the other for genetics or epigenetics studies.
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (Dp1 Clinical Trial Optional) - USA Tender

The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (Dp1 Clinical Trial Optional). This tender is published on USARFP under UST Ref No: 73488891 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-25.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

USARFP Features

USARFP Features

Fresh and verified Tenders from USA. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • New Tenders Every Day
  • Tenders Result Data
  • Archive & Historical Tenders Access
  • Consultants for RFI/RFP/RFQ
  • Tender Notifications & Alerts
  • Search, Sort, and Filter Tenders
  • Bidding Assistance & Consulting
  • Customer Support
  • Publish your Tenders
  • Export data to Excel
  • API for Tender Data
  • Tender Documents
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting USARFP !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from USA in your email inbox.

  Chat with us